Zheng Quan Zhi Xing·2025-05-26 11:22Group 1 - The company, Zhejiang Weihua New Materials Co., Ltd., plans to invest in Lansheng Biotechnology Group Co., Ltd. alongside related party Wu Jiangwei to enhance future profitability [1][6] - The investment involves the company acquiring 624,725 shares of Lansheng Biotechnology, representing 0.6907% of its total equity, for a consideration of 12,086,996 RMB [1][7] - Wu Jiangwei will also acquire shares from other parties, totaling 633,150 shares, for 12,250,000 RMB [1][7] Group 2 - Wu Jiangwei is the chairman and a controlling person of the company, making this investment a related party transaction, but it does not constitute a major asset restructuring [2][9] - The transaction has been approved by the company's board of directors and does not require shareholder approval [2][9] - The company has not engaged in other related party transactions with Wu Jiangwei in the past 12 months, aside from routine transactions [2][9] Group 3 - Lansheng Biotechnology was established on March 7, 2014, with a total registered capital of 90.45 million RMB, and operates in the agricultural chemicals sector [3][4] - The company has total assets of 194,556.71 million RMB and net assets of 127,027.73 million RMB as of December 31, 2024 [6] - The revenue for the year 2024 is projected to be 167,828.95 million RMB, with a net profit of 26,861.89 million RMB [6] Group 4 - The pricing of the shares is based on Lansheng's profitability and net asset scale, ensuring fairness and reasonableness in the transaction [6][8] - The agreement stipulates that the transfer price per share is 19.3477 RMB [7] - The investment is expected to improve the company's profitability and provide better returns for small and medium investors [8][9]